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Abstract
Background: Green	kiwifruit	 is	a	 fiber-rich	fruit	 that	has	been	shown	effective	for	
treatment	of	constipation.	However,	fermentation	of	fibers	by	colonic	bacteria	may	
worsen	commonly	associated	gas-related	abdominal	symptoms.	Aim:	To	determine	
the effect of green kiwifruit on transit and tolerance to intestinal gas in humans.
Methods: In	11	healthy	individuals,	two	gas	challenge	tests	were	performed	(a)	after	
2	weeks	on	a	low-flatulogenic	diet	and	daily	intake	of	2	green	kiwifruits	and	(b)	after	
2 weeks on a similar diet without intake of kiwifruits. The gas challenge test con-
sisted	in	continuous	infusion	of	a	mixture	of	gases	into	the	jejunum	at	12	mL/min	for	
2	hours	while	measuring	rectal	gas	evacuation,	abdominal	symptoms,	and	abdomi-
nal	distension.	During	the	2	weeks	prior	to	each	gas	challenge	test	(on-kiwifruit	and	
off-kiwifruit),	the	number	and	consistency	of	stools,	and	abdominal	symptoms	were	
registered.
Key Results: Intake of kiwifruits was associated with more bowel movements per day 
(1.8	±	0.1	vs	1.5	±	0.1	off-kiwifruit;	P = .001) and somewhat looser stools (Bristol score 
3.3	±	0.2	vs	2.8	±	0.1	off-kiwifruit;	P = .072) without relevant abdominal symptoms. 
Gas	infusion	produced	similar	gas	evacuation	(1238	±	254	mL	and	1172	±	290	mL;	
P	=	.4355),	perception	of	symptoms	(score	1.2	±	0.2	and	1.3	±	0.3;	P	=	.2367),	and	
abdominal distension (17 ± 7 mm and 17 ± 6 mm; P	=	 .4704)	while	on-kiwifruit	or	
off-kiwifruit.
Conclusions and Inferences: In	healthy	subjects,	green	kiwifruit	increases	stool	fre-
quency without relevant effects on intestinal gas transit and tolerance. If confirmed 
in	patients,	these	fruits	may	provide	a	natural	and	well-tolerated	treatment	alterna-
tive for constipation.
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1  | INTRODUC TION
Kiwifruit	is	a	fruit	rich	in	fibers,	C,	E,	and	K	vitamins,	folate,	potassium,	
and other phytochemicals that has been shown to have several benefi-
cial effects on gastrointestinal health.1,2	Specifically,	kiwifruit	has	been	
shown	to	accelerate	gastric	and	colonic	transit,	soften	the	stools,	and	
to	 improve	constipation,	an	effect	 that	can	be	partially	mediated	by	
the high fiber contents of kiwifruit.3-5 Patients with constipation and 
other	 related	 functional	 gut	disorders	 like	 constipation-predominant	
irritable	bowel	syndrome	often	refer	gas-related	abdominal	complains,	
like	bloating	and	abdominal	distension,	that	in	many	cases	are	referred	
as their most bothersome symptoms.6,7	Fibers	have	a	high	potential	
to produce intestinal gas by increasing bacterial fermentation in the 
colon,	and	the	development	of	gas-related	abdominal	symptoms	may	
be a limiting factor for prescription and intake of fibers and some laxa-
tives like lactulose that are fermented by colonic bacteria.8-10
Kiwifruits	contain	1.4-3.0	g.	of	dietary	fiber	per	100	g.	of	fruit.	One	
third	soluble	fiber,	mainly	pectic	polysaccharides,	that	when	reaching	
the colon should be fermented by colonic bacteria and produce gases 
and	short-chain	fatty	acids,	and	two	thirds	insoluble	fiber,	mainly	cel-
lulose and hemicellulose which should not produce any fermentation 
when reaching the colon.1,	2,11 The effect of kiwifruits on gas transit 
and evacuation is uncertain. Previous studies from other laboratories 
have	shown	that	psyllium	and	high-calorie	meals	delay	gas	transit	and	
evacuation.12,13	In	addition,	trapping	of	gas	by	viscous	material,	as	has	
been	described	for	water	after	intake	of	a	similar	quantity	of	kiwifruit,14 
could	delay	gas	transit	and	produce	gas-related	abdominal	symptoms.	
On	the	other	hand,	a	prokinetic	effect	of	kiwifruit5 could accelerate 
transit	and	removal	of	intestinal	gas,	and	thereby	prevent	gas-related	
abdominal symptoms while improving constipation.
The aim of the present study was to determine the effect of green 
kiwifruits on transit and tolerance to intestinal gas in healthy subjects. 
Using	a	previously	developed	and	validated	method	of	 intestinal	gas	
challenge,15-18	we	developed	a	randomized,	cross-over	study	compar-
ing,	on	separate	days,	the	responses	to	a	gas	challenge	test	performed	
after	a	14-day	low-flatulogenic	diet	including	intake	of	two	green	kiwi-
fruits	per	day,	or	after	a	14-day	low-flatulogenic	diet	without	intake	of	
kiwifruit.	Due	to	the	rapid	normal	transit	of	gas	in	healthy	subjects,	a	
concomitant	lipid	infusion	into	the	proximal	duodenum,	mimicking	the	
physiological	postprandial	caloric	load,	was	perfused	during	gas	infu-
sion	to	delay	intestinal	transit	of	gas,	as	used	in	previous	studies.16,19,20
2  | MATERIAL AND METHODS
2.1 | Participants
Eleven healthy individuals (8 women and 3 men; age range 
18-23	years)	without	gastrointestinal	symptoms	participated	in	the	
study.	Subjects	completed	a	pre-entry	questionnaire	 to	determine	
the	absence	of	gastrointestinal	symptoms,	including	abdominal	pain,	
dyspepsia,	bloating,	constipation,	diarrhea,	feeling	of	excessive	ab-
dominal	gas,	excessive	gas	evacuation,	or	belching.	The	protocol	for	
the study had been previously approved by the Ethics Committee of 
the	University	Hospital	Germans	Trias	i	Pujol,	and	all	subjects	gave	
written informed consent before participating in the study.
2.2 | Intervention period
Two	weeks	before	 the	gas	challenge	 test	 (see	below),	participants	
were	instructed	to	follow	a	low-flatulogenic	diet	excluding	legumes,	
vegetables,	garlic,	onion,	cucumber,	nuts,	cereals,	whole-meal	bread,	
and	fizzy	drinks.	In	random	order,	participants	were	assigned	to	eat	
2	green	kiwifruits	without	skins	every	morning	(Zespri	International,	
approximate	weight	150	g	per	kiwifruit),	or	to	follow	the	same	low-
flatulogenic diet but with no intake of kiwifruits.
During	 the	 2-week	 intervention	 periods,	 participants	 filled	 a	
diary	 recording	 in	 separate	 questionnaires	 the	 number	 and	 type,	
according	to	the	Bristol	stool	form	scale,	of	bowel	movements,	the	
intensity	of	abdominal	pain	and	the	intensity	of	abdominal	bloating,	
both	using	0-3	score	scales	were	0	was	no	sensation,	1	mild	sensa-
tion,	2	moderate	sensation	and	3	severe	sensation.	In	addition,	the	
number of kiwifruit ingested was registered.
2.3 | Gas challenge test
The gas challenge test was performed using a methodology that has 
been extensively used and validated in detail.15-18,21-24
2.3.1 | Jejunal gas infusion
Gas	was	continuously	infused	into	the	proximal	jejunum	at	12	mL/
min	 via	 an	 oro-intestinal	 polyvinyl	 tube	 (3.2-mm	 external	 diam-
eter;	 1.6-mm	 internal	 diameter)	 connected	 to	 a	 volumetric	 pump	
Key Points
•	 Green	kiwifruit	is	a	fiber-rich	fruit	that	has	been	shown	
to be effective for treatment of constipation in humans. 
However,	fermentation	of	fibers	by	colonic	bacteria	may	
worsen	 commonly	 associated	 gas-related	 abdominal	
symptoms.
•	 In	 a	 cross-over,	 randomized	 study	 in	 healthy	 subjects,	
intake of green kiwifruit increased bowel movements 
without effects on gas transit and tolerance in response 
to a gas challenge test.
•	 In	 healthy	 subjects,	 the	 fiber-rich	 green	 kiwifruit	 in-
creases stool frequency without relevant effects on 
intestinal gas transit and tolerance. If confirmed in pa-
tients,	these	fruits	may	provide	a	natural	and	well-toler-
ated treatment alternative for constipation.
     |  3 of 8CABALLERO Et AL.
(GIP-3000	 Infusion	 Pump,	 Soifer	 Solucions	 SL).	 The	 gas	 mixture	
infused	 contained	 88%	 nitrogen,	 6.5%	 carbon	 dioxide,	 and	 5.5%	
oxygen mimicking the partial pressures of venous blood gases to 
minimize	diffusion	across	the	intestine-blood	barrier.
2.3.2 | Measurement of rectal gas evacuation
Intestinal	gas	evacuation	was	collected	via	an	intrarectal	Foley	cath-
eter	(20	French;	Bard)	with	the	balloon	inflated	with	5	mL	of	water.	
The	catheter	was	connected	to	a	leak-proof,	 low-resistance	collec-
tion	line,	using	a	barostat,	and	the	volume	continuously	recorded	on	
a	personal	computer,	as	previously	described.
2.3.3 | Lipid infusion
A	mixture	of	lipids	(Intralipid®	20%;	Pharmacia	&	Upjohn,	St	Cugat	
del	Vallés)	diluted	in	saline	was	infused	into	the	duodenum	at	1	mL/
min	(1	Kcal/min)	using	a	volumetric	pump	(Alaris	GH	Plus	Guardrails;	
CareFusion).	Lipids	were	infused	via	a	1.2	mm	ID	channel	added	to	
the	intestinal	tube	assembly,	with	its	distal	port	located	in	the	duo-
denum	15	cm	orad	to	the	gas	infusion	site.
2.3.4 | Intestinal gas tolerance
Conscious	 perception	 was	 measured	 at	 10-minute	 intervals	 by	
means	of	four	graphic	rating	scales,	each	graded	from	0	(no	percep-
tion)	 to	 6	 (painful	 sensation),	 specifically	 for	 scoring	 four	 possible	
types	of	abdominal	sensations:	(a)	pressure/bloating,	(b)	cramp/rum-
bling	sensation,	(c)	puncture/stinging	sensation,	and	(d)	other	type	of	
sensation	(to	be	specified),	respectively.	The	questionnaire	included	
an	additional	tic	box	(YES/NO)	to	signal	belching.	The	location	of	the	
perceived sensations was marked on an abdominal diagram divided 
into	9	regions	corresponding	to	epigastrium,	periumbilical	area,	hy-
pogastrium,	both	hypochondria,	flanks,	and	iliac	fossae.	Participants	
were instructed to report the sensations perceived over the preced-
ing	10-minute	period	in	the	scales.
2.3.5 | Abdominal distension
Once	the	subjects	were	positioned	in	bed	(Section	2.3.6),	a	non-stretch	
48-mm	wide	belt	with	a	metric	 tape	measure	was	adjusted	around	
the	abdomen	over	the	umbilicus	by	means	of	two	elastic	bands.	Girth	
measurements	were	taken	at	10-minute	intervals,	while	the	subjects	
were	breathing	relaxedly,	as	the	average	of	inspiratory	and	expiratory	
determinations over three consecutive respiratory excursions.
2.3.6 | Procedure
After	the	2-week	intervention	period	(see	above),	participants	were	
instructed to have a light dinner the night before the gas challenge 
test,	that	consisted	of	meat,	fish,	eggs,	rice,	pasta,	and/or	white	bread,	
but	 avoiding	 dairy	 products,	 salad,	 fruit,	 and	 alcoholic	 beverages.	
On	the	day	of	the	study,	participants	were	orally	intubated	after	an	
8-hour	fast.	No	kiwifruit	was	eaten	the	day	of	the	study.	The	intestinal	
tube assembly was positioned under fluoroscopic control with the gas 
infusion	port	5	cm	caudad	to	the	angle	of	Treitz.	The	rectal	cannula	
was	introduced,	and	the	subjects	were	then	placed	supine	in	bed	at	an	
angle	of	30°	to	the	horizontal.	The	studies	were	conducted	in	a	quiet,	
isolated room. The tubes were connected to the infusion and collec-
tion	systems,	and	gas	transit	was	continuously	recorded	while	percep-
tion	and	abdominal	girth	were	measured	at	10-minute	intervals.
2.4 | Experimental design
A	 two-period,	 cross-over,	 randomized,	 single-blind	 study	 was	 de-
signed to determine the effect of green kiwifruit intake on gas tran-
sit	and	 tolerance	 (Figure	1).	 In	each	participant,	 two	gas	challenge	
tests	were	performed	with	 a	4-week	 interval.	Gas	 challenge	 tests	
were	preceded	by	a	2-week	 intervention	period	with	 the	 subjects	
on	a	low-flatulogenic	diet	with	or	without	daily	intake	of	2	green	ki-
wifruits.	After	a	2-week	washout	period,	a	new	2-week	intervention	
period started and the second gas challenge test was performed. 
The gas challenge tests were performed with the investigator blind 
for the assigned intervention.
F I G U R E  1   Experimental design. In 
each	participant,	two	gas	challenge	tests	
were	performed	after	2	wk	on-kiwifruit	
and	off-kiwifruit	using	a	randomized	
cross-over	design.	While	on-kiwifruit,	last	
kiwifruit	intake	occurred	24	h,	before	the	
gas challenge test
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2.5 | Data analysis
In	each	subject,	the	number	and	type	of	bowel	movements,	and	the	
intensity	of	perception	during	each	2-week	intervention	periods	were	
registered	for	future	comparisons.	During	each	gas	challenge	test,	in-
testinal gas transit was evaluated by the volume of gas retained within 
the gut (volume infused minus volume collected) at different intervals 
during the study. Perception was measured by the score rated in the 
scales; the highest score (the most severe sensation independently of 
the	type),	instead	of	the	mean	or	cumulative	scores,	was	computed	for	
comparisons.	In	each	subject,	we	also	counted	the	number	of	times	
each abdominal sensation was scored in the repeat measurements 
during the study to calculate the frequency (as percent distribution) 
of	each	specific	 sensation.	 In	 the	anatomical	questionnaire,	we	cal-
culated the percentage of sensations referred over each abdominal 
region,	as	well	as	the	percentage	referred	over	more	than	one	region.	
Changes in abdominal girth during the study were referenced to girth 
measurement	at	the	start	of	the	study,	that	is	before	gas	infusion	was	
started.
2.6 | Statistical analysis
Based on previous studies performed using an identical methodol-
ogy	in	healthy	subjects,15-17 we calculated that a sample size of 10 
subjects per group could discriminate differences in gas retention 
with	a	power	of	80%	and	an	alpha	error	of	5%.
In	each	treatment	period,	mean	values	(±SE)	of	the	parameters	
measured	were	calculated.	The	Kolmogorov-Smirnov	test	was	used	
to check the normality of data distribution. Comparisons of para-
metric,	normally	distributed	data	were	performed	by	the	Student	t 
test	for	paired	data.	Non-parametric	data	were	compared	using	the	
Wilcoxon	signed-rank	test.
3  | RESULTS
3.1 | General aspects
Eleven	healthy	subjects	(8	women	and	3	men;	age	range	18-23	yrs)	
were	 included	 in	 the	study.	All	 the	subjects	completed	 the	2-week	
intervention	period	uneventfully.	All	 subjects	 scored	 intake	of	 two	
kiwifruits,	or	0	kiwifruits,	as	corresponded,	during	the	14	days	prior	
to	each	gas	challenge	test.	All	participants	but	one	completed	the	2	
gas	challenge	test	procedures	as	planned,	so	finally,	the	results	of	10	
healthy subjects who completed the study could be analyzed. The 
reason for withdrawal of one healthy subject was a technical problem 
with	the	gas-recovery	system	that	did	not	allow	measurement	of	gas	
evacuation	during	the	second	gas	transit	procedure.	All	the	remain-
ing 10 participants completed the study without remarkable events.
3.2 | Effects of kiwifruit on abdominal symptoms, 
stool consistency, and frequency
Kiwifruit intake during the 2 weeks preceding the gas transit proce-
dure	was	well-tolerated	by	all	the	subjects	and	induced	neither	ab-
dominal	pain	(score	0.1	±	0.1)	nor	bloating	(score	0.1	±	0.0).	Similarly,	
during	 the	2	weeks	off-kiwifruit	 no	 relevant	 abdominal	 symptoms	
were rated (pain score 0.0 ± 0.0; bloating score 0.1 ± 0.0). The num-
ber	 of	 bowel	movements	was	 somewhat,	 but	 significantly	 greater	
when participants were on a diet including intake of 2 green kiwi-
fruits	per	day	 (1.8	±	0.1	 stools/d),	 than	during	 the	2	weeks	off-ki-
wifruit	 (1.5	±	0.1	stools/d;	P = .001). The consistency of the stools 
measured	by	the	Bristol	Stool	Form	Scale	tended	to	be	softer	while	
on-kiwifruit	 (Figure	 2).	 The	 predominant	 stool	 form	 off-kiwifruit	
was	 Bristol	 3,	 whereas	 the	 predominant	 stool	 form	 on-kiwifruit	
was	Bristol	4,	but	 these	differences	were	minor	and	did	not	reach	
F I G U R E  2  Form	of	stools	according	to	
the	Bristol	Stool	Form	Scale	during	2-wk	
low	flatulogenic	diet	on-kiwifruit	(intake	
of 2 pieces of green kiwifruit per day) and 
off-kiwifruit.	Note	that	the	predominant	
stool	form	moved	from	type	3	while	off-
kiwifruit	to	type	4	on-kiwifruit,	reflecting	
a	looser	consistency	of	stools,	but	within	
the normal range of stool form
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statistical significance (P	=	.068).	Hence,	most	stools	lied	within	the	
normality	range	(Bristol	score	3-5),	and	only	one	subject	while	on-ki-
wifruit	and	one	subject	while	off-kiwifruit	referred	some	loose	stools	
(Bristol 6 or 7) during the intervention period (P	=	.655).
3.3 | Effect of kiwifruit on gas transit during the gas 
challenge test
Gas	 infusion	 produced	 a	 continuous	 evacuation	 of	 gas	 from	 the	
rectum,	 without	 any	 differences	 whether	 gas	 infusion	 was	 per-
formed	after	2	weeks	daily	kiwifruit	intake	or	not	(Figure	3).	Hence,	
after an initial lag time that resulted in a maximal gas retention of 
340	±	122	and	334	±	104	mL	after	70	minutes	of	gas	infusion	(stud-
ies	off-kiwifruit	and	on-kiwifruit,	respectively;	P	=	.484),	at	the	end	
of	the	infusion	period,	participants	had	retained	206	±	280	mL	after	
2	weeks	off-kiwifruit,	and	123	±	250	mL	of	gas	when	gas	 infusion	
was	performed	after	2	weeks	on-kiwifruit	(P = .417).
3.4 | Effect of kiwifruit on abdominal symptoms 
during the gas challenge test
Gas	infusion	was	well-tolerated	by	all	the	subjects	and	produced	a	
mild increment in abdominal perception during the first 60 minutes 
of	 infusion,	 that	 was	 then	maintained	 until	 the	 end	 of	 the	 study,	
without differences whether the gas transit studies were performed 
off-kiwifruit	or	on-kiwifruit	(Figure	3).	Hence,	mean	perception	score	
was	 1.3	 ±	 0.8	 off-kiwifruit	 and	 1.2	 ±	 0.2	 on-kiwifruit	 (P = .4733). 
When	individual	data	were	analyzed,	no	subject	referred	discomfort	
F I G U R E  3   Responses to a gas 
challenge test (infusion of gas into the 
jejunum	al	12	mL/min	for	120	min)	
performed	after	2	wk	on	a	low-
flatulogenic	diet	on-kiwifruit	(intake	of	
2 pieces of green kiwifruit per day) and 
off-kiwifruit.	Observe	that	there	were	
no	differences	in	rectal	gas	evacuation,	
perception of abdominal symptoms or 
objective abdominal distension in the 
studies	performed	on-kiwifruit	and	off-
kiwifruit
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(score	5)	and	only	3	subjects	developed	moderate	perception	(score	
3 or 4) at the end of the gas challenge test in the studies performed 
off-kiwifruit.
The predominant symptoms referred during the gas challenge 
test	were	pressure/bloating	and	cramp/rumbling	sensation,	mainly	
referred	over	 the	abdominal	midline,	without	differences	whether	
the	test	was	performed	on-kiwifruit	or	off-kiwifruit	(data	not	shown).
3.5 | Effect of kiwifruit on objective abdominal 
distension during the gas challenge test
Before	the	start	of	the	gas	infusion	procedure,	at	arrival	to	the	lab-
oratory,	 we	 found	 no	 differences	 in	 abdominal	 girth	whether	 the	
subjects had been eating 2 green kiwifruits per day during 14 days 
(abdominal girth 79.2 ± 3.7 cm) or were not eating kiwifruit (abdomi-
nal	girth	79,7	±	3.7	cm:	P	=	.3058).	Gas	infusion	was	associated	with	a	
minor increment in abdominal girth during the first 60 minutes of gas 
infusion,	that	was	then	maintained	until	the	end	of	the	study,	with-
out	differences	whether	the	gas	transit	studies	were	performed	on-
kiwifruit	or	off-kiwifruit	(Figure	3).	Hence,	final	abdominal	distension	
was	1.7	±	0.6	cm	off-kiwifruit	and	1.7	±	0.7	on-kiwifruit	(P = .4704).
4  | DISCUSSION
In	the	present	study	performed	in	healthy	subjects,	we	have	shown	
that daily intake of two green kiwifruits per day increases stool fre-
quency	and	soften	the	stools	without	inducing	gas-related	abdomi-
nal	symptoms,	without	increasing	rectal	gas	evacuation,	and	without	
effects on gas transit and tolerance to intestinal gas loads.
In	patients	with	constipation,	 increased	dietary	 fibers	are	con-
sidered	 first-line	 treatment	 in	most	of	 the	published	guidelines	on	
chronic constipation and constipation associated with irritable bowel 
syndrome.25-29	However,	patients	with	constipation	often	complain	
of	 associated	 symptoms	 like	 bloating	 and	 abdominal	 distension,	
which may worsen after fiber consumption due to the increased 
intestinal water and gas volumes induced by fermentation of the 
complex polysaccharides that are components of natural fibers.9,30 
Already	in	1969,	Steggerda	described	an	increment	in	flatus	produc-
tion	 following	 consumption	 of	 pinto	 beans,31 and several studies 
published the following years confirmed these observations.32,33 
In	 patients	 with	 functional	 gut	 disorders,	 increased	 colonic	 con-
tents	may	 induce	 bloating	 and	 distension	 by	 several	mechanisms,	
including	visceral	hypersensitivity,34 altered transit and evacuation 
of	gas,18	and	altered	viscero-somatic	reflex	responses	with	abdomi-
no-phrenic	dysfunction.35
Among	the	aliments	that	may	be	useful	for	the	first-line	manage-
ment	of	constipation,	green	kiwifruit	is	a	fiber-rich	fruit	that	has	been	
shown to relief constipation in different clinical trials.2,3	As	most	nat-
ural	aliments,	kiwifruit	contains	a	mixture	of	soluble	and	non-soluble	
fibers.	 Specifically,	 in	 the	present	 study,	 the	 subjects	 consumed	2	
green	kiwifruits	per	day,	a	number	of	fruits	that	have	been	shown	to	
improve	constipation	in	clinical	trials,	containing	9	g	of	dietary	fibers.	
Despite	 its	 potential	 gas	 production,	 during	 the	2	weeks	 kiwifruit	
intake	 participants	 did	 not	 complain	 of	 any	 gas-related	 abdominal	
symptoms,	and	when	a	gas	infusion	test	was	performed,	the	volume	
of	gas	expelled	was	similar	whether	the	subject	had	been	on-kiwi-
fruit	or	off-kiwifruit	during	the	2	weeks	prior	the	gas	infusion	test.	
Previous studies have shown that the increase in gas production in-
duced	by	fibers	depends	on	the	type	of	fibers	ingested.	Hence,	Levitt	
et al36	compared	the	effect	of	lactulose,	the	poorly	fermentable	fiber	
psyllium,	 and	 the	 non-fermentable	 fiber	methylcellulose	 on	 flatus	
production	 in	 healthy	 subjects,	 and	 found	 that	 whereas	 lactulose	
increased	 flatus	production	significantly,	none	of	 the	 fibers	 tested	
induced	any	increment	in	flatus	production.	Likewise,	Gonlachanvit	
et al1 using a similar gas infusion technique as we used in the present 
study found that psyllium consumption delayed gas transit without 
any associated increment in gas evacuation. In a randomized clinical 
trial comparing the effect of psyllium vs a mixture of soluble and 
insoluble	fibers	in	patients	with	constipation,	gas-related	abdominal	
symptoms improved most when the mixed fibers were consumed.37 
Hence,	these	data	may	suggest	that	a	delay	in	gas	transit	induced	by	
some fibers could worsen abdominal symptoms like bloating. In our 
study	using	kiwifruit,	 a	mixture	of	 soluble	and	 insoluble	 fibers,	no	
delay in gaseous transit time was observed after kiwifruit ingestion. 
Previous studies using radiopaque markers have shown that green 
kiwifruit accelerates whole gut transit time in patients with consti-
pation	 and	 constipation-predominant	 irritable	 bowel	 syndrome.2-4 
In	a	 recent	 study	 from	Nottingham	using	MRI	 in	healthy	 subjects,	
the	authors	found	that	ingestion	of	two	green	kiwifruits	per	day,	the	
same	intake	as	we	used	in	the	present	study,	produced	an	increment	
in water content in the small bowel and the ascending colon that 
could account for the increment in stool frequency and looser stool 
consistency observed.14	However,	 in	 this	study,	 the	authors	 found	
the	increment	in	colonic	contents	induced	by	kiwifruit,	smaller	than	
the increment induced by intake of psyllium in previous studies. 
Hence,	kiwifruit	induced	a	rise	in	the	colon	volume	by	16%	whereas	
psyllium	produced	a	50%	increment.	The	authors	conclude	that	ki-
wifruits	have	prokinetic	effects	in	addition	to	water	trapping,	leading	
to less colonic distension. Taking together the results of these stud-
ies,	 it	 seems	 plausible	 that	 a	 prokinetic	 effect	 of	 kiwifruit,	maybe	
associated	with	the	mixed	type	of	fiber	contents,	could	lead	to	lower	
water	and	gas	retention	into	the	colon,	and	result	in	lower	bloating	
and abdominal distension than other dietary fibers or fermentable 
carbohydrates.
In	addition	to	flatus	production,	another	mechanism	that	reduces	
intestinal gases is diffusion of gases to the bloodstream.8 Bacterial 
fermentation	 produces	 different	 gases,	 mainly	 H2,	 CH4, and CO2. 
When	in	the	intestinal	lumen,	these	gases	are	partially	absorbed	to	
the bloodstream. Diffusion of gases depends on the pressure gra-
dient across the intestinal/blood barrier and the solubility in lipids 
of each specific gas.8,38	By	contrast	 to	nitrogen,	which	has	a	poor	
diffusivity,	 gases	 produced	 during	 fermentation	 diffuse	 easily	 to	
the bloodstream. It has been calculated that about 2/3 of the H2 
produced during bacterial fermentation is absorbed under basal 
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conditions.32	Hence,	a	part	of	gases	produced	after	kiwifruit	intake	
can	also	be	cleared	from	the	intestine	by	this	mechanism.	However,	
gas infusion as was performed in the present study produces a wash-
out effect of intestinal gases that should lead to increased rectal gas 
evacuation during the gas infusion procedure if a significant volume 
of gas was produced during kiwifruit intake.17,33	Hence,	even	though	
no	measurement	of	exhaled	gas	was	performed	in	our	study,	our	re-
sults suggest that the volume of intestinal gases produced during 
kiwifruit	intake	is	small,	and	of	low	clinical	significance	for	develop-
ment	of	gas-related	symptoms.
The data of our study apply for healthy subjects with normal 
bowel	habits.	Further	studies	are	necessary	to	determine	the	effects	
of kiwifruits on transit and tolerance of intestinal gas in patients with 
constipation. Previous studies have shown that patients with irrita-
ble bowel syndrome and abdominal bloating have a delayed transit 
of intestinal gas that is associated with abdominal symptoms.16,18 In 
addition,	 these	 patients	may	 be	more	 sensitive	 to	 distension	 than	
healthy controls and so may tolerate kiwifruit less well as is true 
of fructose and fructans.39	Hence,	we	 cannot	 ascertain	 that	 even	
small volumes of gas produced during kiwifruit intake could lead to 
gas	retention	and	gas-related	abdominal	symptoms	in	these	specific	
patients.
In	 the	 present	 study,	 the	 quantity	 of	 fermentable	 fiber	 con-
tained in the kiwifruits administered during the study was smaller 
than the quantity of fibers administered in other studies using 
for example psyllium. This relatively small volume was chosen 
because	 this	 is	 the	 recommended	 for	 treatment	of	 constipation,	
and reflects the clinical consequences of treatment with kiwifruit. 
But	we	cannot	exclude	that	intake	of	greater	number	of	kiwifruits,	
and	thereby	a	greater	quantity	of	fibers,	could	produce	different	
gas-related	 responses,	 as	 previously	 described	 for	 other	 type	of	
fibers.1
The present study was powered to assess the effect of kiwifruit 
on	gas	transit	and	evacuation	in	response	to	a	gas	challenge	test,	but	
not to assess the effect of green kiwifruit on constipation or stool 
consistency.	However,	and	despite	the	 low	number	of	participants	
included,	we	could	see	a	small	but	significant	increment	in	the	num-
ber	 of	 stools,	 and	 a	 tendency	 towards	 looser	 stools	while	 partici-
pants	were	on-kiwifruit,	in	accordance	with	the	previously	reported	
effects of green kiwifruits in patients with constipation.2-4	To	note,	
in	our	cohort	of	healthy	subjects,	these	effects	were	small	and	did	
not lead to diarrhea or an abnormal increment of bowel movements.
In	 conclusion,	 our	 data	have	 shown	 that	 in	 healthy	 subjects,	 a	
daily intake of 2 green kiwifruits per day increases stool frequency 
without relevant effects on intestinal gas transit and tolerance. 
Though our study did not specifically address the clinical effective-
ness	 of	 kiwifruit	 for	 patients	with	 constipation,	 our	 data	 add	 to	 a	
growing	body	of	data	that	these	fruits	may	be	a	natural	and	well-tol-
erated	first-line	treatment	for	patients	with	constipation.
ACKNOWLEDG MENTS
The	 study	 and	 Miss.	 Benslaiman	 position	 were	 funded	 by	 Zespri	
International	Limited,	a	consortium	of	kiwifruit	owners.	Dr	Caballero	
was	 supported	 by	 a	 Grant	 from	 the	 Paraguayan	 Government	
(Programa	 Nacional	 de	 Becas	 de	 Postgrado	 en	 el	 Exterior—Don	
Carlos	Antonio	López,	Fondo	para	la	Excelencia	en	la	Educación	y	la	
Investigación	N°	19/2015).
CONFLIC T OF INTERE S T
This work has been performed as part of the doctoral thesis in medi-
cine	of	Dr	Caballero	at	the	Autonomous	University	of	Barcelona.	Dr	
Serra	has	received	research	funds	from	Salvat,	Zespri,	and	Bayer	and	
acted	as	consulter/speaker	for	AB-biotics,	Allergan,	Bayer,	Norgine,	
Cassen-Recordati,	Zespri,	and	Reckitt	Benkiser.	 Juliet	Ansell	 is	en-
ployed	 by	 Zespri.	 Noemi	 Caballero	 and	 Bouchra	 Benslaiman	 have	
nothing to disclouse.
AUTHOR CONTRIBUTIONS
NC	 involved	 in	 acquisition	 of	 data,	 analysis	 and	 interpretation	 of	
data,	 drafting	 of	 the	 manuscript,	 and	 statistical	 analysis;	 BB	 was	
Nurse	coordinator	and	involved	in	recruitment	of	volunteers	and	ac-
quisition	of	data;	JA	involved	in	study	concept	and	design,	obtained	
funding;	JS	involved	in	study	concept	and	design,	analysis	and	inter-
pretation	of	data,	 critical	 revision	of	 the	manuscript	 for	 important	
intellectual	content,	statistical	analysis,	and	obtained	funding.
ORCID
Jordi Serra  https://orcid.org/0000-0003-2120-6270 
R E FE R E N C E S
	 1.	 Richardson	DP,	Ansell	J,	Drummond	LN.	The	nutritional	and	health	
attributes of kiwifruit: a review. Eur J Nutr.	2018;57(8):2659-2676.
	 2.	 Boland	M,	Moughan	 PJ.	Advances in Food and Nutrition Research. 
Volume 68. Nutritional Benefits of Kiwifruit.	 Vol.	 1st	 ed.	Waltham,	
MA:	Elsevier	Inc.;	2013.
	 3.	 Chan	AOO,	Leung	G,	Tong	T,	Wong	NYH.	Increasing	dietary	fiber	
intake in terms of kiwifruit improves constipation in Chinese pa-
tients. World J Gastroenterol.	2007;13(35):4771-4775.
	 4.	 Chang	CC,	Lin	YT,	Lu	YT,	Liu	YS,	Liu	JF.	Kiwifruit	 improves	bowel	
function in patients with irritable bowel syndrome with constipa-
tion. Asia Pac J Clin Nutr.	2010;19(4):451-457.
	 5.	 Drummond	 L,	 Gearry	 RB.	 Kiwifruit	 modulation	 of	 gastrointes-
tinal motility. In: Advances in Food and Nutrition Research. Vol 68; 
2013:219-232.
	 6.	 Mearin	F,	Lacy	BE,	Chang	L,	et	al.	Bowel	disorders.	In:	Drossman	DA,	
Chang	L,	Chey	WD	et	al,	eds.	ROME IV Functional Gastrointestinal 
Disorders-Disorders of Gut-Brain Interactions.	 4th	 ed.	 Raleigh,	 NC:	
The	Rome	Foundation;	2016:967-1058.
	 7.	 Chang	L,	Lee	OY,	Naliboff	B,	Schmulson	M,	Mayer	EA.	Sensation	of	
bloating and visible abdominal distension in patients with irritable 
bowel syndrome. Am J Gastroenterol.	2001;96(12):3341-3347.
	 8.	 Lee-Robichaud	H,	Thomas	K,	Morgan	J,	Nelson	RL.	Lactulose	ver-
sus	polyethylene	glycol	for	chronic	constipation.	Lee-Robichaud	H,	
ed. Cochrane database Syst Rev.	2010;7;CD007570.
	 9.	 Azpiroz	F.	Intestinal	gas.	In:	Feldman	M,	Friedman	L,	Brandt	LJ,	eds.	
Sleisenger & Fordtran, Gastrointestinal and Liver Disease. 10th ed. 
Philadelphia,	PA:	Elsevier	Saunders;	2016:242-250.
	10.	 Rao	 SSC,	 Yu	 S,	 Fedewa	 A.	 Systematic	 review:	 dietary	 fibre	
and	 FODMAP-restricted	 diet	 in	 the	 management	 of	 consti-
pation and irritable bowel syndrome. Aliment Pharmacol Ther. 
2015;41(12):1256-1270.
8 of 8  |     CABALLERO Et AL.
	11.	 Oku	T,	Nakamura	S.	Evaluation	of	the	relative	available	energy	of	
several dietary fiber preparations using breath hydrogen evolution 
in healthy humans. J Nutr Sci Vitaminol (Tokyo).	2014;60(4):246-254.
	12.	 Gonlachanvit	S,	Coleski	R,	Owyang	C,	Hasler	WL.	Inhibitory	actions	
of a high fibre diet on intestinal gas transit in healthy volunteers. 
Gut.	2004;53(11):1577-1582.
	13.	 Harder	H,	Hernando-Harder	AC,	Franke	A,	Krammer	HJ,	Singer	MV.	
Effect	of	high-	and	low-caloric	mixed	liquid	meals	on	intestinal	gas	
dynamics. Dig Dis Sci.	2006;51(1):140-146.
	14.	 Wilkinson-Smith	V,	Dellschaft	N,	 Ansell	 J,	 et	 al.	Mechanisms	 un-
derlying	effects	of	kiwifruit	on	intestinal	function	shown	by	MRI	in	
healthy volunteers. Aliment Pharmacol Ther.	2019;49(6):759-768.
	15.	 Serra	J,	Azpiroz	F,	Malagelada	JR.	Gastric	distension	and	duodenal	
lipid infusion modulate intestinal gas transit and tolerance in hu-
mans. Am J Gastroenterol.	2002;97(9):2225-2230.
	16.	 Serra	 J,	 Salvioli	 B,	 Azpiroz	 F,	Malagelada	 J.	 Lipid-induced	 intesti-
nal gas retention in irritable bowel syndrome. Gastroenterology. 
2002;123(3):700-706.
	17.	 Serra	J,	Azpiroz	F,	Malagelada	JR.	Intestinal	gas	dynamics	and	toler-
ance in humans. Gastroenterology.	1998;115(3):542-550.
	18.	 Serra	J,	Azpiroz	F,	Malagelada	JR.	Impaired	transit	and	tolerance	of	
intestinal gas in the irritable bowel syndrome. Gut.	2001;48(1):14-19.
	19.	 Lobo	 B,	 Serra	 J,	 D’Amato	M,	 et	 al.	 Effect	 of	 selective	 CCK1	 re-
ceptor antagonism on accommodation and tolerance of intes-
tinal gas in functional gut disorders. J Gastroenterol Hepatol. 
2016;31(2):288-293.
	20.	 Caldarella	 MP,	 Serra	 J,	 Azpiroz	 F,	 Malagelada	 J-R.	 Prokinetic	 ef-
fects in patients with intestinal gas retention. Gastroenterology. 
2002;122(7):1748-1755.
	21.	 Hernando-Harder	 AC,	 Serra	 J,	 Azpiroz	 F,	 Malagelada	 J-R.	 Sites	
of symptomatic gas retention during intestinal lipid perfusion in 
healthy subjects. Gut.	 2004;53(5):661-665.	 http://www.ncbi.nlm.
nih.gov/pubme	d/15082583.	Accessed	February	2,	2017.
	22.	 Harder	H,	Serra	J,	Azpiroz	F,	Passos	MC,	Aguadé	S,	Malagelada	J-
R. Intestinal gas distribution determines abdominal symptoms. Gut. 
2003;52(12):1708-1713.
	23.	 Dainese	 R,	 Serra	 J,	 Azpiroz	 F,	Malagelada	 J-R.	 Influence	 of	 body	
posture on intestinal transit of gas. Gut.	2003;52(7):971-974.	http://
www.ncbi.nlm.nih.gov/pubme	d/12801953.	 Accessed	 February	 2,	
2017.
	24.	 Villoria	A,	Serra	J,	Azpiroz	F,	Malagelada	J-R.	Physical	activity	and	
intestinal gas clearance in patients with bloating. Am J Gastroenterol. 
2006;101(11):2552-2557.
	25.	 Serra	 J,	Mascort-Roca	 J,	Marzo-Castillejo	M,	 et	 al.	 Clinical	 prac-
tice guidelines for the management of constipation in adults. Part 
1:	 Definition,	 aetiology	 and	 clinical	 manifestations.	Gastroenterol 
Hepatol.	2017;40(3):132-141.
	26.	 Tack	 J,	 Müller-Lissner	 S,	 Stanghellini	 V,	 et	 al.	 Diagnosis	 and	
treatment of chronic constipation – a European perspective. 
Neurogastroenterol Motil.	2011;23(8):697-710.
	27.	 Ford	AC,	Moayyedi	P,	Lacy	BE,	et	al.	American	college	of	gastro-
enterology monograph on the management of irritable bowel 
syndrome and chronic idiopathic constipation. Am J Gastroenterol. 
2014;109(S1):S2-S26.
	28.	 Christodoulides	 S,	 Dimidi	 E,	 Fragkos	 KC,	 Farmer	 AD,	Whelan	 K,	
Scott	SM.	Systematic	review	with	meta-analysis:	effect	of	fibre	sup-
plementation on chronic idiopathic constipation in adults. Aliment 
Pharmacol Ther.	2016;44(2):103-116.
	29.	 Serra	J,	Pohl	D,	Azpiroz	F,	et	al.	European	society	of	neurogastro-
enterology and motility guidelines on functional constipation in 
adults. Neurogastroenterol Motil. 2020;32(2):e13762.
	30.	 Molina-Infante	 J,	 Serra	 J,	 Fernandez-Bañares	 F,	 Mearin	 F.	 The	
low-FODMAP	diet	 for	 irritable	bowel	 syndrome:	 lights	and	shad-
ows. Gastroenterol Hepatol.	2016;39(2):55-65.
	31.	 Steggerda	 FR.	 Gastrointestinal	 gas	 following	 food	 consumption.	
Ann NY Acad Sci.	1968;150(1):57-66.	http://www.ncbi.nlm.nih.gov/
pubme	d/4230541.	Accessed	February	2,	2017.
	32.	 Levitt	MD,	Hirsh	P,	Fetzer	CA,	Sheahan	M,	Levine	AS.	H2	excre-
tion after ingestion of complex carbohydrates. Gastroenterol. 
1987;92(2):383-389.	 http://www.ncbi.nlm.nih.gov/pubme	
d/3792775.	Accessed	April	23,	2018.
	33.	 Mego	 M,	 Accarino	 A,	 Malagelada	 JR,	 Guarner	 F,	 Azpiroz	 F.	
Accumulative	effect	of	food	residues	on	intestinal	gas	production.	
Neurogastroenterol Motil.	2015;27(11):1621-1628.
	34.	 Azpiroz	 F,	 Bouin	 M,	 Camilleri	 M,	 et	 al.	 Mechanisms	
of	 hypersensitivity	 in	 IBS	 and	 functional	 disorders.	
Neurogastroenterol Motil.	 2007;19(Suppl	 1):62-88.	 https://doi.
org/10.1111/j.1365-2982.2006.00875.x.
	35.	 Villoria	A,	Azpiroz	F,	Burri	E,	Cisternas	D,	Soldevilla	A,	Malagelada	J-
R.	Abdomino-phrenic	dyssynergia	in	patients	with	abdominal	bloat-
ing and distension. Am J Gastroenterol.	2011;106(5):815-819.
	36.	 Levitt	MD,	Furne	 J,	Olsson	S.	The	 relation	of	passage	of	 gas	 and	
abdominal bloating to colonic gas production. Ann Intern Med. 
1996;124(4):422-424.
	37.	 Erdogan	A,	Rao	SSC,	Thiruvaiyaru	D,	et	al.	Randomised	clinical	trial:	
mixed soluble/insoluble fibre vs. psyllium for chronic constipation. 
Aliment Pharmacol Ther.	2016;44(1):35-44.
	38.	 Pogrund	RS,	Steggerda	FR.	Influence	of	gaseous	transfer	between	
the colon and blood stream on percentage gas compositions of in-
testinal flatus in man. Am J Physiol.	 1948;153(3):475-482.	 http://
www.ncbi.nlm.nih.gov/pubme	d/18882183.	 Accessed	 February	 2,	
2017.
	39.	 Major	 G,	 Pritchard	 S,	 Murray	 K,	 et	 al.	 Colon	 hypersensitivity	 to	
distension,	rather	than	excessive	gas	production,	produces	carbo-
hydrate-related	symptoms	 in	 individuals	with	 irritable	bowel	 syn-
drome. Gastroenterology.	2017;152(1):124-133.e2.
How to cite this article:	Caballero	N,	Benslaiman	B,	Ansell	J,	
Serra	J.	The	effect	of	green	kiwifruit	on	gas	transit	and	
tolerance in healthy humans. Neurogastroenterology & Motility. 
2020;32:e13874. https://doi.org/10.1111/nmo.13874
